These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
571 related articles for article (PubMed ID: 15761769)
1. Elimination of the differential chemoresistance between the murine B-cell lymphoma LY-ar and LY-as cell lines after arsenic (As2O3) exposure via the overexpression of gsto1 (p28). Giri U; Terry NH; Kala SV; Lieberman MW; Story MD Cancer Chemother Pharmacol; 2005 Jun; 55(6):511-21. PubMed ID: 15761769 [TBL] [Abstract][Full Text] [Related]
2. Arsenic trioxide induces apoptosis in cells of MOLT-4 and its daunorubicin-resistant cell line via depletion of intracellular glutathione, disruption of mitochondrial membrane potential and activation of caspase-3. Hu XM; Hirano T; Oka K Cancer Chemother Pharmacol; 2003 Jul; 52(1):47-58. PubMed ID: 12750841 [TBL] [Abstract][Full Text] [Related]
3. Role of GSTP1-1 in mediating the effect of As2O3 in the Acute Promyelocytic Leukemia cell line NB4. Bernardini S; Nuccetelli M; Noguera NI; Bellincampi L; Lunghi P; Bonati A; Mann K; Miller WH; Federici G; Lo Coco F Ann Hematol; 2006 Oct; 85(10):681-7. PubMed ID: 16733740 [TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide-induced apoptosis of Hep-2 cell line through modulating intracellular glutathione (GSH) level. Cheng B; Yang X; An L; Gao B; Liu X Auris Nasus Larynx; 2010 Feb; 37(1):89-94. PubMed ID: 19574005 [TBL] [Abstract][Full Text] [Related]
5. Antimony-trioxide- and arsenic-trioxide-induced apoptosis in myelogenic and lymphatic cell lines, recruitment of caspases, and loss of mitochondrial membrane potential are enhanced by modulators of the cellular glutathione redox system. Lösler S; Schlief S; Kneifel C; Thiel E; Schrezenmeier H; Rojewski MT Ann Hematol; 2009 Nov; 88(11):1047-58. PubMed ID: 19301004 [TBL] [Abstract][Full Text] [Related]
6. Green tea component, catechin, induces apoptosis of human malignant B cells via production of reactive oxygen species. Nakazato T; Ito K; Ikeda Y; Kizaki M Clin Cancer Res; 2005 Aug; 11(16):6040-9. PubMed ID: 16115949 [TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide induces apoptosis through a reactive oxygen species-dependent pathway and loss of mitochondrial membrane potential in HeLa cells. Woo SH; Park IC; Park MJ; Lee HC; Lee SJ; Chun YJ; Lee SH; Hong SI; Rhee CH Int J Oncol; 2002 Jul; 21(1):57-63. PubMed ID: 12063550 [TBL] [Abstract][Full Text] [Related]
8. Intracellular GSH level is a factor in As4.1 juxtaglomerular cell death by arsenic trioxide. Han YH; Kim SZ; Kim SH; Park WH J Cell Biochem; 2008 Jun; 104(3):995-1009. PubMed ID: 18247324 [TBL] [Abstract][Full Text] [Related]
9. Pharmacologic inhibitors of extracellular signal-regulated kinase (ERKs) and c-Jun NH(2)-terminal kinase (JNK) decrease glutathione content and sensitize human promonocytic leukemia cells to arsenic trioxide-induced apoptosis. Ramos AM; Fernandez C; Amrán D; Esteban D; de Blas E; Palacios MA; Aller P J Cell Physiol; 2006 Dec; 209(3):1006-15. PubMed ID: 16972261 [TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide inhibits growth of As4.1 juxtaglomerular cells via cell cycle arrest and caspase-independent apoptosis. Han YH; Kim SZ; Kim SH; Park WH Am J Physiol Renal Physiol; 2007 Aug; 293(2):F511-20. PubMed ID: 17507598 [TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide induces multiple myeloma cell apoptosis via disruption of mitochondrial transmembrane potentials and activation of caspase-3. Jia P; Chen G; Huang X; Cai X; Yang J; Wang L; Zhou Y; Shen Y; Zhou L; Yu Y; Chen S; Zhang X; Wang Z Chin Med J (Engl); 2001 Jan; 114(1):19-24. PubMed ID: 11779429 [TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide triggers a regulated form of caspase-independent necrotic cell death via the mitochondrial death pathway. Scholz C; Wieder T; Stärck L; Essmann F; Schulze-Osthoff K; Dörken B; Daniel PT Oncogene; 2005 Mar; 24(11):1904-13. PubMed ID: 15674346 [TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide mediates intrinsic and extrinsic pathways of apoptosis and cell cycle arrest in acute megakaryocytic leukemia. Lam HK; Li K; Chik KW; Yang M; Liu VC; Li CK; Fok TF; Ng PC; Shing MM; Chuen CK; Yuen PM Int J Oncol; 2005 Aug; 27(2):537-45. PubMed ID: 16010437 [TBL] [Abstract][Full Text] [Related]
14. Role of oxidative stress in the apoptosis of hepatocellular carcinoma induced by combination of arsenic trioxide and ascorbic acid. Li JJ; Tang Q; Li Y; Hu BR; Ming ZY; Fu Q; Qian JQ; Xiang JZ Acta Pharmacol Sin; 2006 Aug; 27(8):1078-84. PubMed ID: 16867262 [TBL] [Abstract][Full Text] [Related]
15. The role of p38 MAPK and JNK in Arsenic trioxide-induced mitochondrial cell death in human cervical cancer cells. Kang YH; Lee SJ J Cell Physiol; 2008 Oct; 217(1):23-33. PubMed ID: 18412143 [TBL] [Abstract][Full Text] [Related]
16. Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines. Sánchez Y; Simón GP; Calviño E; de Blas E; Aller P J Pharmacol Exp Ther; 2010 Oct; 335(1):114-23. PubMed ID: 20605902 [TBL] [Abstract][Full Text] [Related]
17. Resistance to radiation-induced apoptosis in Bcl-2-expressing cells is reversed by depleting cellular thiols. Mirkovic N; Voehringer DW; Story MD; McConkey DJ; McDonnell TJ; Meyn RE Oncogene; 1997 Sep; 15(12):1461-70. PubMed ID: 9333022 [TBL] [Abstract][Full Text] [Related]
18. Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines. Ramos AM; Aller P Biochem Pharmacol; 2008 May; 75(10):1912-23. PubMed ID: 18359480 [TBL] [Abstract][Full Text] [Related]
19. Enhancement of esculetin on arsenic trioxide-provoked apoptosis in human leukemia U937 cells. Lin TH; Lu FJ; Yin YF; Tseng TH Chem Biol Interact; 2009 Jun; 180(1):61-8. PubMed ID: 19428345 [TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide induces apoptosis equally in T lymphoblastoid leukemia MOLT-4 cells and P-gp-expressing daunorubicin-resistant MOLT-4 cells. Hu XM; Hirano T; Oka K Cancer Chemother Pharmacol; 2003 Feb; 51(2):119-26. PubMed ID: 12647012 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]